LAURIE MANCINI: Open Payments
NPI 1609199686 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 8 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $202 · 2025 $443
Food & beverage: $269Education: $174
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $147 |
| Lilly USA, LLC | 1 | $106 |
| AstraZeneca Pharmaceuticals LP | 1 | $68 |
| Gilead Sciences, Inc. | 2 | $51 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| TerSera Therapeutics LLC | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: IMDELLTRA (AMG757), VERZENIO, IMFINZI, Trodelvy, KEYTRUDA, Zoladex, OJJAARA.
Industry payments across MI — which companies pay providers there.
